Advance care planning after lung transplantation: A case of missed opportunities

Progress in Transplantation

Volumn 16, Issue 3, 2006, Pages 222-225

  Song, Mi Kyung ^a   De Vito Dabbs, Annette J ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADULT; BRONCHIOLITIS OBLITERANS; CASE REPORT; COMORBIDITY; CYSTIC FIBROSIS; DISEASE COURSE; DOCUMENTATION; FEMALE; GRAFT REJECTION; HOSPITAL READMISSION; HUMAN; IMMUNOLOGY; INTENSIVE CARE; LENGTH OF STAY; LUNG TRANSPLANTATION; MEDICAL RECORD; ORGANIZATION AND MANAGEMENT; PATIENT CARE; PATIENT CARE PLANNING; REVIEW; STATISTICS; TIME; TREATMENT OUTCOME; TREATMENT WITHDRAWAL;

ADULT; ADVANCE CARE PLANNING; BRONCHIOLITIS OBLITERANS; COMORBIDITY; CYSTIC FIBROSIS; DISEASE PROGRESSION; DOCUMENTATION; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTENSIVE CARE; LENGTH OF STAY; LUNG TRANSPLANTATION; MEDICAL FUTILITY; MEDICAL RECORDS; NURSING RECORDS; PATIENT CARE PLANNING; PATIENT READMISSION; TIME FACTORS; WITHHOLDING TREATMENT;

EID: 33750605444     PISSN: 15269248     EISSN: None     Source Type: Journal    
DOI: 10.7182/prtr.16.3.m77713njx640h307     Document Type: Article

References (27)

1. De Vito Dabbs AJ, Hoffman LA, Iacono A, et al. Pattern and predictors of early allograft rejection after lung transplantation. Am J Crit Care. 2003;12:497-507.
2. Arcasoy SM, Kotloff RM. Lung transplantation. N Engl J Med. 1999;340:1081-1091.
3. Vermeulen KM, Groen H, van der Bij W, Erasmus ME, Koeter GH, TenVergert EM. The effect of bronchiolitis obliterans syndrome on health related quality of life. Clin Transplant. 2004;18:377-383.
4. Gross CR, Savik K, Bolman RM 3rd, Hertz MI. Long-term health status and quality of life outcomes of lung transplant recipients. Chest. 1995;108:1587-1593.
5. Heng D, Sharples LD, McNeil K, Stewart S, Wreghitt T, Wallwork J. Bronchiolitis obliterans syndrome: Incidence, natural history, prognosis, and risk factors. J Heart Lung Transplant. 1998;17:1255-1263.
6. Trulock EP, Edwards LB, Taylor DO, Boucek MM, Keck BM, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: Twenty-first official adult heart transplant report-2004. J Heart Lung Transplant. 2004;23:804-815.
7. Lau CL, Patterson GA, Palmer SM. Critical care aspects of lung transplantation. J Intensive Care Med. 2004;19:83-104.
8. Studer SM, Levy RD, McNeil K, Orens JB. Lung transplant outcomes: A review of survival, graft function, physiology, health-related quality of life and cost-effectiveness. Eur Respir J. 2004;24:674-685.
9. Sundaresan S, Trulock EP, Mohanakumar T, Cooper JD, Patterson GA. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group. Ann Thorac Surg. 1995; 60:1341- 1316; discussion 1346-1347.
10. Kshettry VR, Kroshus TJ, Savik K, Hertz MI, Bolman RM. Primary pulmonary hypertension as a risk factor for the development of obliterative bronchiolitis in lung allograft recipients. Chest. 1996;110:704-709.
11. Dabbs Ade V, Hoffman LA, Swigart V, et al. Striving for normalcy: Symptoms and the threat of rejection after lung transplantation. Soc Sci Med. 2004;59:1473-1484.
12. Mishel MH, Murdaugh CL. Family adjustment to heart transplantation: Redesigning the dream. Nurs Res. 1987;36:332-328.
13. Levine SM. A survey of clinical practice of lung transplantation in North America. Chest. 2004;125:1224-1238.
14. Manzetti JD, Ankeny R, Miller D. Psychosocial and ethical issues in surgical approaches to end-stage lung disease. Clin Chest Med. 1997;18:383-390.
15. Persijn GG, De Meester JM. Demand, supply and allocation in Eurotransplant. Ann Transplant. 1997;2:26-33.
16. Gabbay E, Williams TJ, Griffiths AP, et al. Maximizing the utilization of donor organs offered for lung transplantation. Am J Respir Crit Care Med. 1999;160:265-271.
17. Song MK, Kirchhoff KT, Douglas J, Ward S, Hammes BJ. A randomized, controlled trial to improve advance care planning among patients undergoing cardiac surgery. Med Care. 2005; 43:1049-1053.
18. Verleden GM, Dupont LJ, Van Raemdonck DE. Is it bronchiolitis obliterans syndrome or is it chronic rejection: A reappraisal? Eur Respir J. 2005;25:221-214.
19. Trulock EP, Edwards LB, Taylor DO, et al. The Registry of the International Society for Heart and Lung Transplantation: Twentieth Official adult lung and heart-lung transplant report-2003. J Heart Lung Transplant. 2003;22:625-635.
20. Trulock EP, Edwards LB, Taylor DO, Boucek MM, Keck BM, Hertz MI. Registry of the International Society for Heart and Lung Transplantation: Twenty-second official adult lung and heart-lung transplant report-2005. J Heart Lung Transplant. 2005;24:956-967.
21. Curtis JR, Engelberg RA, Wenrich MD, Shannon SE, Treece PD, Rubenfeld GD. Missed opportunities during family conferences about end-of-life care in the intensive care unit. Am J Respir Crit Care Med. 2005;171:844-849.
22. Moss AH. A new clinical practice guideline on initiation and withdrawal of dialysis that makes explicit the role of palliative medicine. J Palliat Med. 2000;3:253-260.
23. Galla JH. Clinical practice guideline on shared decision-making in the appropriate initiation of and withdrawal from dialysis. Renal Physicians Association and the American Society of Nephrology. J Am Soc Nephrol. 2000;11:1340-1342.
24. Hadjiliadis D, Steele MP, Govert JA, Davis RD, Palmer SM. Outcome of lung transplant patients admitted to the medical ICU. Chest. 2004;125:1040-1045.
25. Ferrin M, Happ MB, Kagan SH. Palliative care and lung transplantation: Conflict or continuum? Am J Nurs. 2001;101:61-66.
26. Lynn J, Goldstein NE. Advance care planning for fatal chronic illness: Avoiding commonplace errors and unwarranted suffering. Ann Intern Med. 2003;138:812-818.
27. Task Force on Palliative Care. Precepts of palliative care. J Palliat Med. 1998;1:109-112.